26447-85-8,
Methyl 2,2-dithienylglycolate,
Methyl 2,2-dithienyl glycolate,
Methyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate,
Methyl di(2-thienyl)glycolate,
Methyl di(2-thienyl) glycolate,
Methyl-2,2-dithienyl Glycolate,
methyl hydroxy(di-2-thienyl)acetate,
AK-27166,
Methyl 2-Hydroxy-2,2-di(2-thienyl)acetate,
methyl 2-hydroxy-2,2-dithiophen-2-ylacetate,
Hydroxy-di-thiophen-2-yl-acetic acid methyl ester,
methyl 2-hydroxy-2,2-bis(thiophen-2-yl)acetate,
AC-607,
PubChem11611,
KSC495G3P,
SCHEMBL826276,
methyl di-(2-thienyl)glycolate,
Jsp005194,
CTK3J5337,
DTXSID10465166,
SYHWYWHVEQQDMO-UHFFFAOYSA-N,
C11H10O3S2,
ACT04264,
BCP12268,
KS-00000J7S,
ZX-RL000403,
2-Thiopheneacetic acid, alpha-hydroxy-alpha-2-thienyl-, methyl ester,
ANW-50433,
CM-509,
DT1469,
FC1278,
MFCD08458380,
ZINC21985909,
methyl hydroxy[di(2-thienyl)]acetate,
AKOS015850983,
ACN-028023,
AN-1158,
API0005060,
CS-W020702,
GS-3211,
RP29069,
RTC-062109,
ACM26447858,
AJ-79421,
BC209184,
BR-27166,
CJ-17112,
OR301120,
SC-20892,
SY021325,
AB0005967,
AB1007058,
AX8019817,
Hydroxydithien-2-ylacetic Acid Methyl Ester,
ST2413302,
TC-062109,
4CH-009810,
FT-0082970,
FT-0645043,
methyl 2-hydroxy-2,2-bis(2-thienyl)acetate,
2,2-Di(2-thienyl)glycolic acid methyl ester,
MFCD08458380 (95%),
M-1555,
methyl 2-oxidanyl-2,2-dithiophen-2-yl-ethanoate,
447M858,
A818447,
2-Hydroxy-2,2-dithien-2-ylacetic acid methyl ester,
I09-1320,
J-016429,
J-521885,
2-hydroxy-2,2-bis(2-thienyl)acetic acid methyl ester,
2-hydroxy-2,2-dithiophen-2-ylacetic acid methyl ester,
2-Thiopheneacetic acid, ?-hydroxy-?-2-thienyl-, methyl ester,
null,
D05MHI,
Methyl2,2-dithienylglycolate,
Di-2-thienylglycolic acid methyl ester,
NG-0711,
CID11414137,
EC 607-936-4,
Methyl 2-hydroxy-2,2-dithiophen-2-yl-acetate,
Multipotent stromal cell therapy (acute renal injury), AlloCure,
Adult mesenchymal stem cell therapy (acute kidney injury), AlloCure,